The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Aliskiren Hemifumarate-Global Market Insights and Sales Trends 2024

Aliskiren Hemifumarate-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1873174

No of Pages : 91

Synopsis
Aliskiren is a direct renin inhibitor that exhibits antihypertensive, antithrombotic, and anti-angiogenic activities. Aliskiren binds to the S3bp binding site of renin, inhibiting its ability to cleave angiotensinin into angiotensin I, therefore preventing the formation of angiotensin II and resulting contraction of arterial smooth muscle. This compound is a vasodilator, decreasing plasma volume and blood pressure in vivo. In animal models of lupus nephritis, aliskiren attenuated proteinuria by decreasing inflammatory cytokine levels and glomerular inflammation. Additionally, in separate animal studies, aliskiren decreases VEGF levels, improves insulin resistance, and prevents development of venous thrombosis.
The global Aliskiren Hemifumarate market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Aliskiren Hemifumarate in various end use industries. The expanding demands from the Pharmaceutical, Health Products, Cosmetic and Other, are propelling Aliskiren Hemifumarate market. 97% Purity, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 98% Purity segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Aliskiren Hemifumarate market, driven by demand from China, the second largest economy with some signs of stabilising, the Aliskiren Hemifumarate market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Aliskiren Hemifumarate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Aliskiren Hemifumarate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Aliskiren Hemifumarate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Aliskiren Hemifumarate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Aliskiren Hemifumarate covered in this report include Ambeed, BioCrick, Caming Pharmaceutical, Clearsynth, Ivy Fine Chemicals, NK Chemiosys, Shanghai Ruifu Chemical and Shimadzu GLC Ltd, etc.
The global Aliskiren Hemifumarate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Ambeed
BioCrick
Caming Pharmaceutical
Clearsynth
Ivy Fine Chemicals
NK Chemiosys
Shanghai Ruifu Chemical
Shimadzu GLC Ltd
Global Aliskiren Hemifumarate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Aliskiren Hemifumarate market, Segment by Type:
97% Purity
98% Purity
99% Purity
Global Aliskiren Hemifumarate market, by Application
Pharmaceutical
Health Products
Cosmetic
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Aliskiren Hemifumarate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Aliskiren Hemifumarate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Aliskiren Hemifumarate Market Overview
1.1 Aliskiren Hemifumarate Product Overview
1.2 Aliskiren Hemifumarate Market Segment by Type
1.2.1 97% Purity
1.2.2 98% Purity
1.2.3 99% Purity
1.3 Global Aliskiren Hemifumarate Market Size by Type
1.3.1 Global Aliskiren Hemifumarate Market Size Overview by Type (2018-2029)
1.3.2 Global Aliskiren Hemifumarate Historic Market Size Review by Type (2018-2023)
1.3.3 Global Aliskiren Hemifumarate Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Aliskiren Hemifumarate Sales Breakdown by Type (2018-2023)
1.4.2 Europe Aliskiren Hemifumarate Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Aliskiren Hemifumarate Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Aliskiren Hemifumarate Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Aliskiren Hemifumarate Sales Breakdown by Type (2018-2023)
2 Global Aliskiren Hemifumarate Market Competition by Company
2.1 Global Top Players by Aliskiren Hemifumarate Sales (2018-2023)
2.2 Global Top Players by Aliskiren Hemifumarate Revenue (2018-2023)
2.3 Global Top Players by Aliskiren Hemifumarate Price (2018-2023)
2.4 Global Top Manufacturers Aliskiren Hemifumarate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Aliskiren Hemifumarate Market Competitive Situation and Trends
2.5.1 Aliskiren Hemifumarate Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Aliskiren Hemifumarate Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aliskiren Hemifumarate as of 2022)
2.7 Date of Key Manufacturers Enter into Aliskiren Hemifumarate Market
2.8 Key Manufacturers Aliskiren Hemifumarate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Aliskiren Hemifumarate Status and Outlook by Region
3.1 Global Aliskiren Hemifumarate Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Aliskiren Hemifumarate Historic Market Size by Region
3.2.1 Global Aliskiren Hemifumarate Sales in Volume by Region (2018-2023)
3.2.2 Global Aliskiren Hemifumarate Sales in Value by Region (2018-2023)
3.2.3 Global Aliskiren Hemifumarate Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Aliskiren Hemifumarate Forecasted Market Size by Region
3.3.1 Global Aliskiren Hemifumarate Sales in Volume by Region (2024-2029)
3.3.2 Global Aliskiren Hemifumarate Sales in Value by Region (2024-2029)
3.3.3 Global Aliskiren Hemifumarate Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Aliskiren Hemifumarate by Application
4.1 Aliskiren Hemifumarate Market Segment by Application
4.1.1 Pharmaceutical
4.1.2 Health Products
4.1.3 Cosmetic
4.1.4 Other
4.2 Global Aliskiren Hemifumarate Market Size by Application
4.2.1 Global Aliskiren Hemifumarate Market Size Overview by Application (2018-2029)
4.2.2 Global Aliskiren Hemifumarate Historic Market Size Review by Application (2018-2023)
4.2.3 Global Aliskiren Hemifumarate Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Aliskiren Hemifumarate Sales Breakdown by Application (2018-2023)
4.3.2 Europe Aliskiren Hemifumarate Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Aliskiren Hemifumarate Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Aliskiren Hemifumarate Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Aliskiren Hemifumarate Sales Breakdown by Application (2018-2023)
5 North America Aliskiren Hemifumarate by Country
5.1 North America Aliskiren Hemifumarate Historic Market Size by Country
5.1.1 North America Aliskiren Hemifumarate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Aliskiren Hemifumarate Sales in Volume by Country (2018-2023)
5.1.3 North America Aliskiren Hemifumarate Sales in Value by Country (2018-2023)
5.2 North America Aliskiren Hemifumarate Forecasted Market Size by Country
5.2.1 North America Aliskiren Hemifumarate Sales in Volume by Country (2024-2029)
5.2.2 North America Aliskiren Hemifumarate Sales in Value by Country (2024-2029)
6 Europe Aliskiren Hemifumarate by Country
6.1 Europe Aliskiren Hemifumarate Historic Market Size by Country
6.1.1 Europe Aliskiren Hemifumarate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Aliskiren Hemifumarate Sales in Volume by Country (2018-2023)
6.1.3 Europe Aliskiren Hemifumarate Sales in Value by Country (2018-2023)
6.2 Europe Aliskiren Hemifumarate Forecasted Market Size by Country
6.2.1 Europe Aliskiren Hemifumarate Sales in Volume by Country (2024-2029)
6.2.2 Europe Aliskiren Hemifumarate Sales in Value by Country (2024-2029)
7 Asia-Pacific Aliskiren Hemifumarate by Region
7.1 Asia-Pacific Aliskiren Hemifumarate Historic Market Size by Region
7.1.1 Asia-Pacific Aliskiren Hemifumarate Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Aliskiren Hemifumarate Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Aliskiren Hemifumarate Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Aliskiren Hemifumarate Forecasted Market Size by Region
7.2.1 Asia-Pacific Aliskiren Hemifumarate Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Aliskiren Hemifumarate Sales in Value by Region (2024-2029)
8 Latin America Aliskiren Hemifumarate by Country
8.1 Latin America Aliskiren Hemifumarate Historic Market Size by Country
8.1.1 Latin America Aliskiren Hemifumarate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Aliskiren Hemifumarate Sales in Volume by Country (2018-2023)
8.1.3 Latin America Aliskiren Hemifumarate Sales in Value by Country (2018-2023)
8.2 Latin America Aliskiren Hemifumarate Forecasted Market Size by Country
8.2.1 Latin America Aliskiren Hemifumarate Sales in Volume by Country (2024-2029)
8.2.2 Latin America Aliskiren Hemifumarate Sales in Value by Country (2024-2029)
9 Middle East and Africa Aliskiren Hemifumarate by Country
9.1 Middle East and Africa Aliskiren Hemifumarate Historic Market Size by Country
9.1.1 Middle East and Africa Aliskiren Hemifumarate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Aliskiren Hemifumarate Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Aliskiren Hemifumarate Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Aliskiren Hemifumarate Forecasted Market Size by Country
9.2.1 Middle East and Africa Aliskiren Hemifumarate Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Aliskiren Hemifumarate Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Ambeed
10.1.1 Ambeed Company Information
10.1.2 Ambeed Introduction and Business Overview
10.1.3 Ambeed Aliskiren Hemifumarate Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Ambeed Aliskiren Hemifumarate Products Offered
10.1.5 Ambeed Recent Development
10.2 BioCrick
10.2.1 BioCrick Company Information
10.2.2 BioCrick Introduction and Business Overview
10.2.3 BioCrick Aliskiren Hemifumarate Sales, Revenue and Gross Margin (2018-2023)
10.2.4 BioCrick Aliskiren Hemifumarate Products Offered
10.2.5 BioCrick Recent Development
10.3 Caming Pharmaceutical
10.3.1 Caming Pharmaceutical Company Information
10.3.2 Caming Pharmaceutical Introduction and Business Overview
10.3.3 Caming Pharmaceutical Aliskiren Hemifumarate Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Caming Pharmaceutical Aliskiren Hemifumarate Products Offered
10.3.5 Caming Pharmaceutical Recent Development
10.4 Clearsynth
10.4.1 Clearsynth Company Information
10.4.2 Clearsynth Introduction and Business Overview
10.4.3 Clearsynth Aliskiren Hemifumarate Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Clearsynth Aliskiren Hemifumarate Products Offered
10.4.5 Clearsynth Recent Development
10.5 Ivy Fine Chemicals
10.5.1 Ivy Fine Chemicals Company Information
10.5.2 Ivy Fine Chemicals Introduction and Business Overview
10.5.3 Ivy Fine Chemicals Aliskiren Hemifumarate Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Ivy Fine Chemicals Aliskiren Hemifumarate Products Offered
10.5.5 Ivy Fine Chemicals Recent Development
10.6 NK Chemiosys
10.6.1 NK Chemiosys Company Information
10.6.2 NK Chemiosys Introduction and Business Overview
10.6.3 NK Chemiosys Aliskiren Hemifumarate Sales, Revenue and Gross Margin (2018-2023)
10.6.4 NK Chemiosys Aliskiren Hemifumarate Products Offered
10.6.5 NK Chemiosys Recent Development
10.7 Shanghai Ruifu Chemical
10.7.1 Shanghai Ruifu Chemical Company Information
10.7.2 Shanghai Ruifu Chemical Introduction and Business Overview
10.7.3 Shanghai Ruifu Chemical Aliskiren Hemifumarate Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Shanghai Ruifu Chemical Aliskiren Hemifumarate Products Offered
10.7.5 Shanghai Ruifu Chemical Recent Development
10.8 Shimadzu GLC Ltd
10.8.1 Shimadzu GLC Ltd Company Information
10.8.2 Shimadzu GLC Ltd Introduction and Business Overview
10.8.3 Shimadzu GLC Ltd Aliskiren Hemifumarate Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Shimadzu GLC Ltd Aliskiren Hemifumarate Products Offered
10.8.5 Shimadzu GLC Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Aliskiren Hemifumarate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Aliskiren Hemifumarate Industrial Chain Analysis
11.4 Aliskiren Hemifumarate Market Dynamics
11.4.1 Aliskiren Hemifumarate Industry Trends
11.4.2 Aliskiren Hemifumarate Market Drivers
11.4.3 Aliskiren Hemifumarate Market Challenges
11.4.4 Aliskiren Hemifumarate Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Aliskiren Hemifumarate Distributors
12.3 Aliskiren Hemifumarate Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’